Back to search

Article

DNA Nanoflower Enables Controlled Co-Delivery of Antisense Oligodeoxynucleotide and Doxorubicin for Anti-breast Cancer Treatment

2025-02-21

Abstract excerpt

Doxorubicin (DOX), an anthracycline antibiotic, is widely used to treat a range of solid tumors and hematological malignancies. However, its clinical application in breast cancer is hindered by toxic side effects and the development of multidrug resistance (MDR). Enhancing the selective targeting of DOX and overcoming MDR are critical to improving treatment efficacy. Here, we present a DNA nanoflower (DNF)-based d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
60669e70-6528-5621-9fb3-5c53d059d711
DOI
10.22541/au.174017526.63124569/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DNA Nanoflower Enables Controlled Co-Delivery of Antisense Oligodeoxynucleotide and Doxorubicin for Anti-breast Cancer TreatmentDOI 10.22541/au.174017526.63124569/v1
Select a neighboring publication to make it the new centre.